Magdy Z. El-Ghanam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Magdy Z. El-Ghanam has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed M. Tahon
Department of Clinical Pathology, Faculty of Medicine, Al-Azhar University, Nasr City, Cairo, Egypt
1 shared publication - Ali M. Bersy
Department of Clinical Pathology, Faculty of Medicine, Al-Azhar University, Damietta, Egypt
1 shared publication - Amr M. El Kharsawy
Department of Clinical Pathology, Faculty of Medicine, Al-Azhar University, Damietta, Egypt
1 shared publication - Dina Johar
Biochemistry and Nutrition Department, Faculty of Women for Arts, Sciences, and Education, Ain Shams University, Heliopolis, Cairo, Egypt
1 shared publication - Elsayed A.Z.
Faculty of Sciences, Jouf University, Jouf, Kingdom of Saudi Arabia
1 shared publication - Fathiya El-Raey
Department of Tropical Medicine, Faculty of Medicine, Al-Azhar University, Nasr City, Cairo, Egypt
1 shared publication
Latest Publications
- 6 April 2018
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 50 (3) , 434-441
Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients
Background Egypt has high incidence of hepatocellular carcinoma (HCC). This is due to wide spread of hepatitis C virus (HCV) infection which is responsible for most of the cases of liver cirrhosis. The major diagnostic techniques for HCC include serum markers and various imaging modalities. Glypican 3 (GPC3) protein is highly expressed in HCC, but not in normal liver tissue. The significance of GPC3 as a predictor or diagnostic tool for human tumors other than HCC is unclear. Aim To quantitatively assess the role of GPC3 in diagnosis of HCC in comparison to α-fetoprotein (AFP), ultrasonography (US), and computerized tomography (CT). Patients and Methods This cross-sectional study enrolled 85 subjects: 40 cirrhotic patients with primary HCC, 30 cirrhotic patients without HCC, and 15 healthy individuals. All patients were recruited from the Gastroenterology and Tropical Departments and outpatient clinics of New Damietta Hospital during the period from November 2010 to August 2012. Results GPC3 is positive in some HCC patients with normal levels of AFP. AFP has lower sensitivity (67.5%) compared to higher sensitivity of GPC3 (82.5%), and near specificity (61.2%) to GPC3 (57.8%). Conclusion and Significance The combined serum AFP and GPC3 significantly increased the sensitivity of HCC diagnosis. Although GPC3 is better than AFP in diagnosis of HCC, it still lacks the 100% sensitivity and specificity because some patients have negative or normal level of GPC3 (below the cutoff point 1.5 ng/ml) despite being diagnosed by triphasic CT.
- 6 April 2018
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 50 (3) , 434-441
Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients
Background Egypt has high incidence of hepatocellular carcinoma (HCC). This is due to wide spread of hepatitis C virus (HCV) infection which is responsible for most of the cases of liver cirrhosis. The major diagnostic techniques for HCC include serum markers and various imaging modalities. Glypican 3 (GPC3) protein is highly expressed in HCC, but not in normal liver tissue. The significance of GPC3 as a predictor or diagnostic tool for human tumors other than HCC is unclear. Aim To quantitatively assess the role of GPC3 in diagnosis of HCC in comparison to α-fetoprotein (AFP), ultrasonography (US), and computerized tomography (CT). Patients and Methods This cross-sectional study enrolled 85 subjects: 40 cirrhotic patients with primary HCC, 30 cirrhotic patients without HCC, and 15 healthy individuals. All patients were recruited from the Gastroenterology and Tropical Departments and outpatient clinics of New Damietta Hospital during the period from November 2010 to August 2012. Results GPC3 is positive in some HCC patients with normal levels of AFP. AFP has lower sensitivity (67.5%) compared to higher sensitivity of GPC3 (82.5%), and near specificity (61.2%) to GPC3 (57.8%). Conclusion and Significance The combined serum AFP and GPC3 significantly increased the sensitivity of HCC diagnosis. Although GPC3 is better than AFP in diagnosis of HCC, it still lacks the 100% sensitivity and specificity because some patients have negative or normal level of GPC3 (below the cutoff point 1.5 ng/ml) despite being diagnosed by triphasic CT.